Species differences in tumour responses to cancer chemotherapy

Keyphrases

• Tumor Response 100%
• Cancer Chemotherapy 100%
• Species Differences 100%
• Cancer Chemotherapy Drugs 66%
• Cancer Patients 33%
• Pharmacokinetics-pharmacodynamics (PK-PD) 33%
• Phase I Clinical Trial 33%
• Oncology Studies 33%
• Phase II Clinical Trial 33%
• Drug Development 33%
• Human Cancer 33%
• Radiotherapy 33%
• Chemotherapy 33%
• Clinical Practice 33%
• Conventional Chemotherapy 33%
• Oncology 33%
• Cancer Incidence 33%
• Comparative Oncology 33%
• Development Pathways 33%
• Pet Dogs 33%
• High Mortality 33%
• Chemotherapy Drugs 33%
• High Morbidity 33%
• Rational Drug Design 33%
• Species Variation 33%
• Veterinary Patients 33%
• Targeted Drug Development 33%
• Rodent Models 33%
• Pharmacogenomics 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cancer Chemotherapy 100%
• Chemotherapy 100%
• Malignant Neoplasm 100%
• Neoplasm 100%
• Drug Development 66%
• Clinical Trial 33%
• Pharmacodynamics 33%
• Pharmacogenomics 33%
• Pet Animal 33%
• Cancer Drug Development 33%
• Disease 33%
• Pharmacokinetics 33%